Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masafumi Kumano

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Oncology Letters|August 1, 2012
Growth inhibition and enhanced chemosensitivity induced by down-regulation of Aurora-A in human renal cell carcinoma Caki-2 cells using short hairpin RNATomoaki Terakawa, Hideaki Miyake, Masafumi Kumano, et al.
Current Urology|June 12, 2014
Significance of random bladder biopsies in non-muscle invasive bladder cancerMasafumi Kumano, Hideaki Miyake, Yuzo Nakano, et al.
International Journal of Clinical Oncology|September 11, 2013
Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in JapanHideaki Miyake, Ken-Ichi Harada, Masafumi Kumano, et al.
Medical Oncology (Northwood, London, England)|October 15, 2013
Sequential use of mammalian target of rapamycin inhibitors in patients with metastatic renal cell carcinoma following failure of tyrosine kinase inhibitorsMasafumi Kumano, Hideaki Miyake, Ken-ichi Harada, et al.
Micromachines|November 15, 2018
Bonding-Based Wafer-Level Vacuum Packaging Using Atomic Hydrogen Pre-Treated Cu Bonding FramesKoki Tanaka, Hideki Hirano, Masafumi Kumano, et al.
Oncology Reports|September 30, 2010
The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cellsTomoaki Terakawa, Hideaki Miyake, Masafumi Kumano, et al.
BJU International|November 17, 2009
Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer modelMasafumi Kumano, Hideaki Miyake, Tomoaki Terakawa, et al.
Urologic Oncology|May 11, 2010
Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resectionMototsugu Muramaki, Hideaki Miyake, Tomoaki Terakawa, et al.
International Urology and Nephrology|May 19, 2009
Characterization of prostate cancer incidentally detected in radical cystoprostatectomy specimens from Japanese men with bladder cancerToshifumi Kurahashi, Hideaki Miyake, Junya Furukawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 17, 2005
[Is second course intravesical Bacillus Calmette-Guerin therapy for recurrent carcinoma in situ of the bladder useful?]Yuji Yamada, Isao Hara, Masafumi Kumano, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Oncology Letters|August 1, 2012
Growth inhibition and enhanced chemosensitivity induced by down-regulation of Aurora-A in human renal cell carcinoma Caki-2 cells using short hairpin RNATomoaki Terakawa, Hideaki Miyake, Masafumi Kumano, et al.
Current Urology|June 12, 2014
Significance of random bladder biopsies in non-muscle invasive bladder cancerMasafumi Kumano, Hideaki Miyake, Yuzo Nakano, et al.
International Journal of Clinical Oncology|September 11, 2013
Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in JapanHideaki Miyake, Ken-Ichi Harada, Masafumi Kumano, et al.
Medical Oncology (Northwood, London, England)|October 15, 2013
Sequential use of mammalian target of rapamycin inhibitors in patients with metastatic renal cell carcinoma following failure of tyrosine kinase inhibitorsMasafumi Kumano, Hideaki Miyake, Ken-ichi Harada, et al.
Micromachines|November 15, 2018
Bonding-Based Wafer-Level Vacuum Packaging Using Atomic Hydrogen Pre-Treated Cu Bonding FramesKoki Tanaka, Hideki Hirano, Masafumi Kumano, et al.
Oncology Reports|September 30, 2010
The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cellsTomoaki Terakawa, Hideaki Miyake, Masafumi Kumano, et al.
BJU International|November 17, 2009
Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer modelMasafumi Kumano, Hideaki Miyake, Tomoaki Terakawa, et al.
Urologic Oncology|May 11, 2010
Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resectionMototsugu Muramaki, Hideaki Miyake, Tomoaki Terakawa, et al.
International Urology and Nephrology|May 19, 2009
Characterization of prostate cancer incidentally detected in radical cystoprostatectomy specimens from Japanese men with bladder cancerToshifumi Kurahashi, Hideaki Miyake, Junya Furukawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 17, 2005
[Is second course intravesical Bacillus Calmette-Guerin therapy for recurrent carcinoma in situ of the bladder useful?]Yuji Yamada, Isao Hara, Masafumi Kumano, et al.
Pageof 3